Ajinomoto Bio-Pharma Services Competitors and Similar CompaniesClear all

Oxford BioTherapeutics's competitors and similar companies include CytomX Therapeutics, ADC Therapeutics, Lexicon Pharmaceuticals and Anika Therapeutics.
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
ADC Therapeutics
ADC Therapeutics
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Anika Therapeutics
Anika Therapeutics
Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.
Founding Date
Founding Date
2004
Founding Date
2008
Founding Date
2010
Founding Date
1995
Founding Date
1992
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Milton, GB HQ
San Jose, US
Locations
South San Francisco, US HQ
Locations
Epalinges, CH HQ
London, GB
New Providence, US
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Bernards, US
Birmingham, US
Boston, US
Charlotte, US
see more
Locations
Bedford, US HQ
Padova, IT
Padova, IT
Franklin, US
Employees
Employees
482% decrease
Employees
15815% increase
Employees
1162% increase
Employees
20216% increase
Employees
15416% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
91.4 m
Valuation ($)
318.1 m
Valuation ($)
610.9 m
Valuation ($)
369.8 m

Financial

Revenue (est.)
Revenue (est.)
£2.1m (FY, 2018)
Revenue (est.)
$101.2m (FY, 2023)
Revenue (est.)
$69.6m (FY, 2023)
Revenue (est.)
$1.2m (FY, 2023)
Revenue (est.)
$166.7m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1.3m (FY, 2023)
Cost of goods
$85k (FY, 2023)
Cost of goods
$63.6m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$68.2m (FY, 2023)
Gross profit
N/A
Gross profit
$103.1m (FY, 2023)
Net income
Net income
(£6.5m) (FY, 2018)
Net income
($569k) (FY, 2023)
Net income
($234.5m) (FY, 2023)
Net income
($177.1m) (FY, 2023)
Net income
($82.7m) (FY, 2023)

Operating

Patents (Foreign)
Patents (Foreign)
N/A
Patents (Foreign)
4 (FY, 2016)
Patents (Foreign)
N/A
Patents (Foreign)
N/A
Patents (Foreign)
151 (FY, 2016)
Patents (US)
Patents (US)
N/A
Patents (US)
13 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
21 (FY, 2016)
Patents Pending
Patents Pending
N/A
Patents Pending
144 (FY, 2016)
Patents Pending
N/A
Patents Pending
N/A
Patents Pending
14 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Pre-Clinical Phase Products
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
4 (FY, 2016)
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
1 (FY, 2016)
Pre-Clinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 21.6m
Total funding raised
$ 132.4m
Total funding raised
$ 526m
Total funding raised
$ 244.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
ADC Therapeutics
HQ
Epalinges, CH
Employees
116↑ 2% increase

ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.

View company
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
Anika Therapeutics
HQ
Bedford, US
Employees
154↑ 16% increase

Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.

View company